Trevi Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89532M1018

SecurityTRVI / Trevi Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership1,201,489 shares
Latest Disclosed Value $ 14,333,764
Citadel Advisors Llc ownership in TRVI / Trevi Therapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 1,201,489 shares of Trevi Therapeutics, Inc. (US:TRVI) valued at $14,333,764 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 152,855 shares of Trevi Therapeutics, Inc.. This represents a change in shares of 686.03% during the quarter. The current value of the position is $16,160,027 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (TRVI) in the form of stock options. The firm currently holds call options representing 105,100 of underlying shares valued at $1,253,843 USD and put options representing 46,800 of underlying shares valued at $558,324 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TRVI / Trevi Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TREVI THERAPEUTICS COM 89532M101 1,201,489 1,048,634 686.03 14,334 649.24 0.0020
2026-02-17 2025-12-31 13F TREVI THERAPEUTICS COM 89532M101 152,855 50,321 49.08 1,914 103.94 0.0003
2025-11-14 2025-09-30 13F TREVI THERAPEUTICS COM 89532M101 102,534 -1,216,732 -92.23 938 -87.00 0.0001
2025-08-14 2025-06-30 13F TREVI THERAPEUTICS COM 89532M101 1,319,266 1,319,266 7,216 0.0013
2025-05-15 2025-03-31 13F TREVI THERAPEUTICS COM 89532M101 0 -1,233,176 -100.00 0 -100.00
2025-02-14 2024-12-31 13F TREVI THERAPEUTICS COM 89532M101 1,233,176 1,183,295 2,372.24 5,081 2,960.24 0.0009
2024-11-14 2024-09-30 13F TREVI THERAPEUTICS COM 89532M101 49,881 49,881 167 0.0000
2024-08-14 2024-06-30 13F TREVI THERAPEUTICS COM 89532M101 0 -28,680 -100.00 0 -100.00
2024-05-15 2024-03-31 13F TREVI THERAPEUTICS COM 89532M101 28,680 -156,378 -84.50 99 -60.32 0.0000
2024-02-14 2023-12-31 13F TREVI THERAPEUTICS COM 89532M101 185,058 157,977 583.35 248 318.64 0.0000
2023-11-14 2023-09-30 13F TREVI THERAPEUTICS COM 89532M101 27,081 -33,372 -55.20 59 -59.03 0.0000
2023-08-14 2023-06-30 13F TREVI THERAPEUTICS COM 89532M101 60,453 -11,202 -15.63 144 9.09 0.0000
2023-05-15 2023-03-31 13F TREVI THERAPEUTICS COM 89532M101 71,655 27,439 62.06 133 55.29 0.0000
2023-02-14 2022-12-31 13F TREVI THERAPEUTICS COM 89532M101 44,216 44,216 85 0.0000
2022-05-16 2022-03-31 13F TREVI THERAPEUTICS COM 89532M101 0 -49,849 -100.00 0 -100.00
2022-02-14 2021-12-31 13F TREVI THERAPEUTICS COM 89532M101 49,849 31,702 174.70 39 56.00 0.0000
2021-11-15 2021-09-30 13F TREVI THERAPEUTICS Cmn 89532M101 18,147 18,147 25 0.0000
2021-08-16 2021-06-30 13F TREVI THERAPEUTICS COM 89532M101 0 -10,617 -100.00 0 -100.00
2021-05-21 2021-03-31 13F/A-1 TREVI THERAPEUTICS COM 89532M101 10,617 10,617 29 0.0000
2021-05-17 2021-03-31 13F TREVI THERAPEUTICS COM 89532M101 10,617 10,617 29 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TREVI THERAPEUTICS COM Call 105,100 98.68 1,254 89.27 n/a n/a n/a
2026-02-17 2025-12-31 13F TREVI THERAPEUTICS COM Call 52,900 18.08 662 61.86 n/a n/a n/a
2025-11-14 2025-09-30 13F TREVI THERAPEUTICS COM Call 44,800 -77.44 410 -62.34 n/a n/a n/a
2025-08-14 2025-06-30 13F TREVI THERAPEUTICS COM Call 198,600 83.55 1,086 59.71 n/a n/a n/a
2025-05-15 2025-03-31 13F TREVI THERAPEUTICS COM Call 108,200 529.07 681 871.43 n/a n/a n/a
2025-02-14 2024-12-31 13F TREVI THERAPEUTICS COM Call 17,200 2,766.67 71 3,400.00 n/a n/a n/a
2024-11-14 2024-09-30 13F TREVI THERAPEUTICS COM Call 600 2 n/a n/a n/a
2024-08-14 2024-06-30 13F TREVI THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F TREVI THERAPEUTICS COM Call 2,200 22.22 8 250.00 n/a n/a n/a
2024-02-14 2023-12-31 13F TREVI THERAPEUTICS COM Call 1,800 2 n/a n/a n/a
2023-11-14 2023-09-30 13F TREVI THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F TREVI THERAPEUTICS COM Call 1,000 -9.09 2 0.00 n/a n/a n/a
2023-05-15 2023-03-31 13F TREVI THERAPEUTICS COM Call 1,100 -8.33 2 0.00 n/a n/a n/a
2023-02-14 2022-12-31 13F TREVI THERAPEUTICS COM Call 1,200 2 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TREVI THERAPEUTICS COM Put 46,800 -48.00 558 -50.44 n/a n/a n/a
2026-02-17 2025-12-31 13F TREVI THERAPEUTICS COM Put 90,000 -61.21 1,127 -46.94 n/a n/a n/a
2025-11-14 2025-09-30 13F TREVI THERAPEUTICS COM Put 232,000 171.66 2,123 354.39 n/a n/a n/a
2025-08-14 2025-06-30 13F TREVI THERAPEUTICS COM Put 85,400 205.00 467 165.34 n/a n/a n/a
2025-05-15 2025-03-31 13F TREVI THERAPEUTICS COM Put 28,000 -43.43 176 -13.30 n/a n/a n/a
2025-02-14 2024-12-31 13F TREVI THERAPEUTICS COM Put 49,500 1,000.00 204 1,253.33 n/a n/a n/a
2024-11-14 2024-09-30 13F TREVI THERAPEUTICS COM Put 4,500 15 n/a n/a n/a
2024-08-14 2024-06-30 13F TREVI THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F TREVI THERAPEUTICS COM Put 600 -80.00 2 -50.00 n/a n/a n/a
2024-02-14 2023-12-31 13F TREVI THERAPEUTICS COM Put 3,000 4 n/a n/a n/a
2023-08-14 2023-06-30 13F TREVI THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F TREVI THERAPEUTICS COM Put 47,400 315.79 88 295.45 n/a n/a n/a
2023-02-14 2022-12-31 13F TREVI THERAPEUTICS COM Put 11,400 22 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.